A Study of LY3556050 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India
- Status
- COMPLETED
- Phase
- PHASE4
A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis
- Status
- TERMINATED
- Phase
- PHASE1
A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)
- Status
- COMPLETED
- Phase
- PHASE3
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Mirikizumab in Healthy Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3471851 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of LY3471851 in Participants With Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Safety Study of LY3372689 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3435151 in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)
- Status
- RECRUITING
- Phase
- PHASE3